Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.
3.
4.

Protection against gram-negative bacteremia in neutropenic mice with recombinant granulocyte-macrophage colony-stimulating factor.

Bermudez LE, Martinelli JC, Gascon R, Wu M, Young LS.

Cytokine. 1990 Jul;2(4):287-93.

PMID:
1966550
5.
9.

Phase I trial of granulocyte-macrophage colony-stimulating factor plus high-dose cyclophosphamide given every 2 weeks: a Cancer and Leukemia Group B study.

Lichtman SM, Ratain MJ, Van Echo DA, Rosner G, Egorin MJ, Budman DR, Vogelzang NJ, Norton L, Schilsky RL.

J Natl Cancer Inst. 1993 Aug 18;85(16):1319-26.

PMID:
8340944
11.

Protective effect of human granulocyte colony-stimulating factor on microbial infection in neutropenic mice.

Matsumoto M, Matsubara S, Matsuno T, Tamura M, Hattori K, Nomura H, Ono M, Yokota T.

Infect Immun. 1987 Nov;55(11):2715-20.

13.

[Prevention and treatment of febrile neutropenia].

Montemurro F, Gallicchio M, Aglietta M.

Tumori. 1997;83(2 Suppl):S15-9. Review. Italian.

PMID:
9235724
14.

Granulocyte-colony stimulating factor facilitates the restoration of resistance to opportunistic fungi in leukopenic mice.

Uchida K, Yamamoto Y, Klein TW, Friedman H, Yamaguchi H.

J Med Vet Mycol. 1992;30(4):293-300.

PMID:
1279154
17.

Macrophage-colony stimulating factor is required for the production of neutrophil-promoting activity by mouse embryo fibroblasts deficient in G-CSF and GM-CSF.

Zhang HH, Basu S, Wu F, Begley CG, Saris CJ, Dunn AR, Burgess AW, Walker F.

J Leukoc Biol. 2007 Oct;82(4):915-25. Epub 2007 Jul 25.

PMID:
17652450
19.
20.

Protective effect of recombinant murine granulocyte-macrophage colony-stimulating factor against Pseudomonas aeruginosa infection in leukocytopenic mice.

Tanaka T, Okamura S, Okada K, Suga A, Shimono N, Ohhara N, Hirota Y, Sawae Y, Niho Y.

Infect Immun. 1989 Jun;57(6):1792-9.

Supplemental Content

Support Center